Expression of Leukemia Inhibitory Factor (LIF) in the Clomiphene Citrate Treated Infertile Women with Luteal Phase Defect.
- Author:
Seung Hee GOH
1
;
Jung Hye HWANG
;
Se Jin JANG
Author Information
1. Department of Obstetrics and Gynecology, School of Medicine, Inje University, Korea.
- Publication Type:Original Article
- Keywords:
Leukemia inhibitory factor (LIF);
Clomiphene citrate;
Luteal phase defect
- MeSH:
Biopsy;
Cervix Mucus;
Clomiphene*;
Cytokines;
Endometrium;
Epithelial Cells;
Estrogen Receptor Modulators;
Female;
Humans;
Infertility;
Intercellular Signaling Peptides and Proteins;
Leukemia Inhibitory Factor*;
Leukemia*;
Luteal Phase*;
Menstrual Cycle;
Ovulation;
Pregnancy Rate;
Stromal Cells
- From:Korean Journal of Obstetrics and Gynecology
2003;46(11):2221-2226
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVE: Although the regulation of implantation is not clearly understood, recent studies have revealed that many cytokines and growth factors play an essential role in preimplantation endometrial development. Among the cytokines, the expression of leukemia inhibitory factor (LIF) is absolutely essential for implantation, although its precise role is not fully understood. Clomiphene citrate is most commonly used drug in the treatment of infertility, but pregnancy rate achieved with clomiphene citrate is significantly lower than the ovulation rate due to the antiestrogenic effect of it on the cervical mucus and endometrium. The our purpose was to evaluate the endometrial expression of LIF in clomiphene citrate treated infertile women with luteal phase defect and association of clomiphene citrate and unsatisfactory endometrial development. METHODS: The endometrial samples from women with luteal phase defect (n=27) were examined. The endometrial tissue was obtained during secretory phase in 5 cases, and during proliferative phase in 6 cases without clomiphene citrate treatment. In 16 cases, the endometrial tissue was obtained by biopsy during secretory phase after clomiphene citrate treatment. Immunohistochemical staining was performed for LIF in the endometrial tissues. And then the expression of LIF was compared between clomiphene citrate treatment group and no treatment group during secretory phase, and secretory and proliferative phase were compared in the no treatment group. RESULTS: The endometrial expression of LIF was not significantly different between clomiphene citrate treated group and no treated group (p. value=0.123) and between proliferative phase and secretory phase without clomiphene citrate (p. value=0.306). The expressions of LIF were detected mostly in glandular epithelial cells and not in the stromal cells. CONCLUSION: We demonstrated that LIF was expressed in glandular epithelial cells rather than stromal cells and there was not menstrual cycle dependent difference of endometrial expression of LIF in infertile women with luteal phase defect. And our finding suggested that clomiphene citrate did not affect the secretory phase endometrial expression of LIF in infertile women with luteal phase defect.
